benzyl-alpha-n-acetylgalactosamine has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahire, SD; Bane, SM; Ingle, AD; Kalraiya, RD; Srinivasan, N | 1 |
Burdick, MD; Hayashi, T; Hinoda, Y; Hollingsworth, MA; Imai, K; Satoh, S | 1 |
2 other study(ies) available for benzyl-alpha-n-acetylgalactosamine and Lung Neoplasms
Article | Year |
---|---|
Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3.
Topics: Acetylgalactosamine; Animals; Antigens, Tumor-Associated, Carbohydrate; Benzyl Compounds; Biotinylation; Cell Adhesion; Cell Line, Tumor; Cell Membrane; Flow Cytometry; Galectin 3; Humans; Immobilized Proteins; Lung Neoplasms; Melanoma; Mice; Oligosaccharides; Organ Specificity; Polysaccharides; Protein Binding | 2009 |
Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule.
Topics: Acetylgalactosamine; Animals; Benzyl Compounds; Cell Adhesion; Cell Division; Cell Movement; Extracellular Matrix Proteins; Humans; Kinetics; Lung Neoplasms; Mice; Mice, Nude; Mucin-1; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Recombinant Proteins; Sequence Deletion; Transfection; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2000 |